SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Integrated Proteins Ltd (519606) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 519606 NSE: | Trading | Small Cap

Integ.Pro Share Price

83 1.12 (1.37%)
As on 10-Apr'26 16:59

Integrated Proteins Ltd (519606)

BSE: 519606 NSE:
Key Metrics
Market Cap
₹155 Cr.
P/E Ratio
626.30
Price to Book (P/B)
7.76
Price to Sales (P/S)
6.05
EV/EBITDA
447.63
Return on Capital Employed (ROCE)
2.40%
Current Price
₹83
Return on Equity (ROE)
10.34%
Return on Assets (ROA)
1.42%
Operating Profit Margin
0.5%
Net Profit Margin
1.16%
Gross Profit Margin
1.5%
Book Value per Share
₹10.7
Sales Growth (YoY)
8858.33%
Sales Growth (3 Years)
NA%
Operating Profit Growth (1 Year)
NA%
Operating Profit Growth (3 Years)
N/A%
Net Profit Growth (1 Year)
177.78%
52-Week Low / High
₹21 / 84
Net Profit Growth (3 Years)
89.91%
Dividend Yield
0.00%
Promoter Holding
2.23%
Pledged shares (%)
of Promoter's holding (%)
0.00%

Check Before You Invest

Q.1
Integrated Proteins Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.
Q.1 Gross Profit margin of Integrated Proteins Ltd?
Integrated Proteins Ltd Gross profit margin which is the profit after deduction of direct costs, is 1.5% for FY-2025 , which is above its 5 year median of 0% , indicating increasing margins.
Q.1 Promoter shareholding and pledge status of Integrated Proteins Ltd?
Promoters hold 2.23% of the Integrated Proteins Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Revenue growth of Integrated Proteins Ltd vs industry peers?
Integrated Proteins Ltd revenue CAGR is 0.00% , compared to the industry median CAGR of 17.75% , indicating slower growth and losing its market share.
Q.1 Stock return of Integrated Proteins Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 44.2% based on the current price.
Q.1 Is Integrated Proteins Ltd a good quality company?
Integrated Proteins Ltd is a quality company, based on a 10 year financial track record .

DeciZen - make an informed investing decision on Integ.Pro

Based on:

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Overvalued

3. Price Trend

Weak

Integrated Proteins stock performance

Key Ratios
mw4me loader

Is Integrated Proteins Ltd an attractive stock to invest in?

1. Is Integrated Proteins Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Integrated Proteins Ltd is a below average quality company.

2. Is Integrated Proteins Ltd undervalued or overvalued?

The key valuation ratios of Integrated Proteins Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Integrated Proteins Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Integrated Proteins Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Integrated Proteins Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 3.4%3.3%2.5%0.2%0.8%1.2%2%1.6%3.9%2.4%-
Value Creation
Index
-0.8-0.8-0.8-1.0-1.0-0.9-0.9-0.9-0.7-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 0.10000000.20.221.526
Sales YoY Gr.--100%NANANANANANA41.2%8,858.3%-
Adj EPS 0.20.100.100.10.10.10.10.60.1
YoY Gr.--43.5%-69.2%100%-75%250%57.1%-9.1%-20%675%-
BVPS (₹) 7.17.26.96.66.66.76.86.97.27.910.7
Adj Net
Profit
0.10.100000000.20
Cash Flow from Ops. -0.1-0.2-0.2-0.1-0.2-0.1-0.1-0.1-0.1-23.6-
Debt/CF from Ops. 00000-0.4-0.9-1.6-0.6-0.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 86.2%NANA8858.3%
Adj EPS 11.7%98.7%78%675%
BVPS1.3%3.7%5.4%10.8%
Share Price 44.2% 91.3% 89.2% 72.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
3.41.90.510.20.91.51.211.71.4
Op. Profit
Mgn %
-77.6000000-51.1-49.90.51.3
Net Profit
Mgn %
102.400000018.510.30.91
Debt to
Equity
00000000.101.4-
Working Cap
Days
6,9350000004,7953,371292187
Cash Conv.
Cycle
-1,298000000-100-39-69130

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 1.40%

Net Profit is growing at healthy rate in last 3 years 77.96%

Sales growth is good in last 4 quarters at 4788.54%

Sales growth has been subdued in last 3 years 0.00%

Latest Financials

Standalone Consolidated
TTM EPS (₹) 0.1 -
TTM Sales (₹ Cr.) 25.7 -
BVPS (₹) 10.7 -
Reserves (₹ Cr.) 1 -
P/BV 7.76 -
PE 626.30 -
From the Market
52 Week Low / High (₹) 20.71 / 83.51
All Time Low / High (₹) 1.55 / 81.88
Market Cap (₹ Cr.) 155
Equity (₹ Cr.) 18.7
Face Value (₹) 10
Industry PE 24.2

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Integ.Pro - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales00000000021
Operating Expenses + 00000000021
Manufacturing Costs0000000000
Material Costs00000000021
Employee Cost 0000000000
Other Costs 0000000000
Operating Profit -0-0-0-0-0-0-0-0-00
Operating Profit Margin (%) -77.6%-------51.1%-49.9%0.4%
Other Income + 0000000000
Exceptional Items 0000000000
Interest 0000000000
Depreciation 0000000000
Profit Before Tax 0000000000
Tax 000-0000000
Profit After Tax 0000000000
PAT Margin (%) 102.4%------18.5%37.6%1.2%
Adjusted EPS (₹)0.20.10.00.10.00.10.10.10.30.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 2332222333
Share Capital 4444444444
Reserves -1-1-1-1-1-1-1-1-1-1
Debt +0000000004
Long Term Debt0000000000
Short Term Debt0000000004
Minority Interest0000000000
Trade Payables0000000008
Others Liabilities 00000000018
Total Liabilities 33333333332

Fixed Assets

Net Fixed Assets +1111000000
Gross Block1111111111
Accumulated Depreciation0011111111
CWIP 0000000000
Investments 0000000000
Inventories0000000000
Trade Receivables0000000000
Cash Equivalents 0000000000
Others Assets 22222222232
Total Assets 33333333332

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + -0-0-0-0-0-0-0-0-0-24
PBT 0000000000
Adjustment -0-0-0-0-0-0-0-0-0-0
Changes in Working Capital -0-0-00-00-0-0-0-24
Tax Paid 00-0-0-00-0-0-0-0
Cash Flow From Investing Activity + 0000000-002
Capex 0000000000
Net Investments 0000000-000
Others 0000000002
Cash Flow From Financing Activity + 000-00000-021
Net Proceeds from Shares 00000000017
Net Proceeds from Borrowing 00000000-0-0
Interest Paid 000-0000000
Dividend Paid 0000000000
Others 0000000004
Net Cash Flow 0-0-0-0-0-0-0-0-00

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.391.910.511.140.2611.691.413.9710.34
ROCE (%)3.433.342.540.150.761.171.951.593.892.4
Asset Turnover Ratio0.030000000.060.091.22
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days87000000000
Inventory Days0000000000
Payable Days00000001355770

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Integrated Proteins Ltd FAQs

The current trading price of Integ.Pro on 10-Apr-2026 16:59 is ₹83.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Apr-2026 the market cap of Integ.Pro stood at ₹155.3 Cr

The latest P/E ratio of Integ.Pro as of 09-Apr-2026 is 626.3.

The latest P/B ratio of Integ.Pro as of 09-Apr-2026 is 7.76.

The 52-week high of Integ.Pro is ₹83.51 and the 52-week low is ₹20.71.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Integ.Pro is ₹25.68 ( Cr.) .

About Integrated Proteins Ltd

Integrated Proteins Limited was incorporated on October 14, 1992. Since inception, the Company is engaged in processing of various oil seeds like soyabean, mustard/ rapeseed, groundnut, etc. business with wide /various range depending on ultimate application of the products. However, Gujarat enjoys a strong position with regard to availability of groundnut and mustard/rapeseed.

Business area of the company

The company is engaged in the business of Trading in processing of various oil seeds like soyabean, musted/rapeseed, groundnut, etc. business with wide/various range depending on ultimate application of the products. The main object of the company is to cater to the growing industry and offer its products to all the age groups. The company is slowly processing towards becoming a one stop shop for all the retailers.

You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×